Literature DB >> 18443638

Monitoring opioid adherence in chronic pain patients: tools, techniques, and utility.

Laxmaiah Manchikanti1, Sairam Atluri, Andrea M Trescot, James Giordano.   

Abstract

Opioids are important, if not essential, agents in treating certain types of chronic pain. However, the prevalence of drug misuse, abuse, and addiction has fostered considerable consternation among physicians, who may hesitate to prescribe these medications both due to concern for patients (misuse, abuse, and addiction), and fears of prosecution and/or professional sanction. Such practice may reflect 1) inadequate knowledge about patients' susceptibility to, or current drug misuse or abuse; 2) lack of familiarity with extant assessments and/or regulations, and/or 3) an unanticipated reaction to existing guidelines, policies or laws. We posit that assessing patients' predisposition to, and patterns of, drug misuse/abuse is a vital first step toward establishing and maintaining the safe and effective use of opioid analgesics in the treatment of chronic pain. Adherence monitoring is critical to identify patients' prior and current drug use, establish treatment basis, and evaluate compliance, so as to avoid misuse and abuse, and ensure sound and proper pain management. This paper provides a review of the numerous monitoring approaches that have been described in the literature and addresses the benefits and limitations of these techniques and tools. The complex nature of the problem of drug misuse and abuse is discussed, and while no single monitoring technique can fully address this complex issue, we describe how multiple approaches to adherence monitoring may be employed to sustain the prudent use of opioids for the treatment of chronic pain.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18443638

Source DB:  PubMed          Journal:  Pain Physician        ISSN: 1533-3159            Impact factor:   4.965


  17 in total

1.  Screening for addictive disorders within a workers' compensation clinic: an exploratory study.

Authors:  Iman Parhami; Mark Hyman; Aaron Siani; Stephanie Lin; Michael Collard; Johnny Garcia; Laurie Casaus; John Tsuang; Timothy W Fong
Journal:  Subst Use Misuse       Date:  2011-11-08       Impact factor: 2.164

2.  Use of prescription pain medications among medical cannabis patients: comparisons of pain levels, functioning, and patterns of alcohol and other drug use.

Authors:  Brian E Perron; Kipling Bohnert; Angela K Perone; Marcel O Bonn-Miller; Mark Ilgen
Journal:  J Stud Alcohol Drugs       Date:  2015-05       Impact factor: 2.582

Review 3.  Caring for patients with opioid use disorder in the hospital.

Authors:  Joseph H Donroe; Stephen R Holt; Jeanette M Tetrault
Journal:  CMAJ       Date:  2016-09-19       Impact factor: 8.262

Review 4.  Adherence monitoring with chronic opioid therapy for persistent pain: a biopsychosocial-spiritual approach to mitigate risk.

Authors:  Deborah Matteliano; Barbara J St Marie; June Oliver; Candace Coggins
Journal:  Pain Manag Nurs       Date:  2012-10-23       Impact factor: 1.929

5.  The ecology of prescription opioid abuse in the USA: geographic variation in patients' use of multiple prescribers ("doctor shopping").

Authors:  Douglas C McDonald; Kenneth E Carlson
Journal:  Pharmacoepidemiol Drug Saf       Date:  2014-08-11       Impact factor: 2.890

Review 6.  Strategies to reduce the tampering and subsequent abuse of long-acting opioids: potential risks and benefits of formulations with physical or pharmacologic deterrents to tampering.

Authors:  Steven P Stanos; Patricia Bruckenthal; Robert L Barkin
Journal:  Mayo Clin Proc       Date:  2012-07       Impact factor: 7.616

7.  Provider Misinterpretation, Documentation, and Follow-Up of Definitive Urine Drug Testing Results.

Authors:  Isaac Chua; Athena K Petrides; Gordon D Schiff; Jaime R Ransohoff; Michalis Kantartjis; Jocelyn Streid; Christiana A Demetriou; Stacy E F Melanson
Journal:  J Gen Intern Med       Date:  2019-11-11       Impact factor: 5.128

8.  Development of a Clinically Viable Heroin Vaccine.

Authors:  Paul T Bremer; Joel E Schlosburg; Matthew L Banks; Floyd F Steele; Bin Zhou; Justin L Poklis; Kim D Janda
Journal:  J Am Chem Soc       Date:  2017-06-20       Impact factor: 15.419

9.  Global changes in the rat heart proteome induced by prolonged morphine treatment and withdrawal.

Authors:  Zdenka Drastichova; Jitka Skrabalova; Petr Jedelsky; Jan Neckar; Frantisek Kolar; Jiri Novotny
Journal:  PLoS One       Date:  2012-10-09       Impact factor: 3.240

10.  Estimating the prevalence of opioid diversion by "doctor shoppers" in the United States.

Authors:  Douglas C McDonald; Kenneth E Carlson
Journal:  PLoS One       Date:  2013-07-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.